4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-051911
Chief Accounting Officer sold 2,418 shares at $27.25 ($65,889)
- Chief Accounting Officer acquired 2,418 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-02 | Option exercise 10b5-1 | +2,418 | $11.35 | $27,444 | 8,272 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-02 | Sale 10b5-1 | −2,418 | $27.25 | $65,889 | 5,854 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-10-02 | Option exercise · Stock option (right to buy) 10b5-1 | −2,418 | 2,418 | D | ||
| Open-market sales · 2,418 sh · avg $27.25 · $65,889 | |||||||
Loading xslF345X05/ownership.xml…